Joseph Jenrette to Female
This is a "connection" page, showing publications Joseph Jenrette has written about Female.
Connection Strength
0.281
-
Rosai-Dorfman disease: management of CNS and systemic involvement. Clin Adv Hematol Oncol. 2012 Mar; 10(3):199-202.
Score: 0.021
-
Central nervous system myelomatosis with optic neuropathy and intramedullary spinal cord compression responding to radiation therapy. Jpn J Radiol. 2011 Aug; 29(7):513-6.
Score: 0.021
-
Radiation therapy for B-cell cutaneous lymphoid hyperplasia. Jpn J Radiol. 2010 Jun; 28(5):385-7.
Score: 0.019
-
Six-year experience: long-term disease control outcomes for partial breast irradiation using MammoSite balloon brachytherapy. Am J Surg. 2010 Feb; 199(2):204-9.
Score: 0.018
-
Late chest wall toxicity after MammoSite breast brachytherapy. Brachytherapy. 2009 Jan-Mar; 8(1):19-25.
Score: 0.017
-
A case of orbital Rosai-Dorfman disease responding to radiotherapy. J Pediatr Hematol Oncol. 2008 Oct; 30(10):744-8.
Score: 0.017
-
Incidence and prognostic factors for seroma development after MammoSite breast brachytherapy. Brachytherapy. 2008 Oct-Dec; 7(4):305-9.
Score: 0.017
-
The role of radiotherapy in the management of resected uterine papillary serous and clear cell carcinoma. Eur J Obstet Gynecol Reprod Biol. 2008 Dec; 141(2):163-8.
Score: 0.017
-
Definitive radiotherapy for medically inoperable early-stage serous and clear cell uterine carcinoma. Radiat Med. 2007 Dec; 25(10):536-40.
Score: 0.016
-
Delayed skin toxicity in MammoSite breast brachytherapy. Am J Clin Oncol. 2006 Dec; 29(6):645-6.
Score: 0.015
-
Chest wall dose in MammoSite breast brachytherapy: radiobiologic estimations of late complication risk based on dose-volume considerations. Brachytherapy. 2005; 4(4):259-63.
Score: 0.013
-
Management of treatment-resistant cutaneous sarcoidosis with radiation. Am J Clin Oncol. 2002 Dec; 25(6):573-5.
Score: 0.011
-
Intermediate-risk meningioma: initial outcomes from NRG Oncology RTOG 0539. J Neurosurg. 2018 07; 129(1):35-47.
Score: 0.008
-
Pediatric Patients Demonstrate Progressive T1-Weighted Hyperintensity in the Dentate Nucleus following Multiple Doses of Gadolinium-Based Contrast Agent. AJNR Am J Neuroradiol. 2016 Dec; 37(12):2340-2347.
Score: 0.007
-
Ultrasound-guided tandem placement for low-dose-rate brachytherapy in advanced cervical cancer minimizes risk of intraoperative uterine perforation. Ultrasound Obstet Gynecol. 2011 Feb; 37(2):241-4.
Score: 0.005
-
Glioneuronal tumor with neuropil-like islands of the spinal cord with diffuse leptomeningeal neuraxis dissemination. J Neurooncol. 2011 Sep; 104(2):529-33.
Score: 0.005
-
Outcomes in women treated with MammoSite brachytherapy or whole breast irradiation stratified by ASTRO Accelerated Partial Breast Irradiation Consensus Statement Groups. Int J Radiat Oncol Biol Phys. 2012 Jan 01; 82(1):21-9.
Score: 0.005
-
A Phase II study of anti-epidermal growth factor receptor radioimmunotherapy in the treatment of glioblastoma multiforme. J Neurosurg. 2010 Aug; 113(2):192-8.
Score: 0.005
-
Mammographic surveillance after MammoSite breast brachytherapy: analysis of architectural patterns and additional interventions. Am J Clin Oncol. 2007 Dec; 30(6):574-9.
Score: 0.004
-
Multi-institutional experience using the MammoSite radiation therapy system in the treatment of early-stage breast cancer: 2-year results. Int J Radiat Oncol Biol Phys. 2008 May 01; 71(1):107-14.
Score: 0.004
-
Predictors of cosmetic outcome following MammoSite breast brachytherapy: a single-institution experience of 100 patients with two years of follow-up. Int J Radiat Oncol Biol Phys. 2007 Jun 01; 68(2):354-8.
Score: 0.004
-
GliaSite brachytherapy for treatment of recurrent malignant gliomas: a retrospective multi-institutional analysis. Neurosurgery. 2006 Apr; 58(4):701-9; discussion 701-9.
Score: 0.004
-
Acute complications of MammoSite brachytherapy: a single institution's initial clinical experience. Int J Radiat Oncol Biol Phys. 2005 Jan 01; 61(1):169-74.
Score: 0.003
-
Outcome of radiation therapy for renal transplant rejection refractory to chemical immunosuppression. Radiother Oncol. 2005 Jan; 74(1):17-9.
Score: 0.003
-
Skin toxicity during breast irradiation: pathophysiology and management. South Med J. 2004 Oct; 97(10):989-93.
Score: 0.003
-
Vulvar cancer in a patient with Fanconi's anemia, treated with 3D conformal radiotherapy. Am J Hematol. 2004 Jun; 76(2):148-51.
Score: 0.003
-
Fetal dose during radiotherapy: clinical implementation and review of the literature. Cancer Radiother. 2002 Dec; 6(6):352-7.
Score: 0.003
-
Desmoid tumors in a woman with idiopathic multicentric osteolysis: result of three etiologic factors or coincidence? Am J Clin Oncol. 2000 Aug; 23(4):376-8.
Score: 0.002
-
Interparenchymal hemorrhagic neurocytoma: an atypical presentation of a rare CNS tumor. Med Pediatr Oncol. 1999 Jun; 32(6):440-6.
Score: 0.002
-
Dynamic stereotactic radiosurgery: the Charleston program: a report on the first 150 patients. J S C Med Assoc. 1998 May; 94(5):218-21.
Score: 0.002
-
Combined modality therapy in the treatment of epidermoid carcinoma of the anus at the Medical University of South Carolina. J S C Med Assoc. 1993 Jul; 89(7):333-6.
Score: 0.001
-
Primary malignant extragonadal germ cell tumors. An analysis of the effect of the effect of radiotherapy. Cancer. 1990 Jun 15; 65(12):2681-5.
Score: 0.001
-
Intraperitoneal P-32 after negative second-look laparotomy in ovarian carcinoma. Cancer. 1989 Jun 15; 63(12):2434-7.
Score: 0.001
-
The management of early breast cancer (clinical stage I). J S C Med Assoc. 1988 May; 84(5):231-3.
Score: 0.001
-
Epidermoid carcinoma of the anus. Surg Gynecol Obstet. 1982 Nov; 155(5):745-51.
Score: 0.001